Lam Research (LRCX) reported its fiscal Q3 2026 earnings (calendar Q1 2026, quarter ended March 29, 2026) after market close on April 22, 2026. The company delivered record quarterly revenue of $5.84 billion, beating analyst estimates and posting a significant earnings surprise. Here is a complete breakdown of Lam Research LRCX Q1 2026 earnings results, forward guidance, and key investment takeaways.

Lam Research (LRCX) Q1 2026 Earnings Results: Record $5.84B Revenue, EPS Beats by 8% — Full Analysis 🏆

Last Updated: April 23, 2026 | Sources: Lam Research 8-K Filing, Quiver Quantitative, StockTitan, GuruFocus, TipRanks

📊 Q1 2026 Earnings Snapshot — Across-the-Board Beat

Lam Research Corporation (NASDAQ: LRCX) released its fiscal third quarter 2026 results on April 22, 2026, covering the period ended March 29, 2026 — equivalent to calendar Q1 2026. The semiconductor equipment maker delivered its highest-ever quarterly revenue, expanded margins sequentially, and issued a blockbuster guide for the June quarter. Below is the complete data breakdown verified against the official 8-K filing.

💰 Key Financial Metrics — FY2026 Q3 (Calendar Q1 2026)

Metric	Actual	Analyst Estimate	YoY Change
Revenue	$5.84B	$5.76B–$5.88B	▲ +23.8%
GAAP Diluted EPS	$1.45	$1.35	▲ +39.4%
Non-GAAP Diluted EPS	$1.47	$1.36–$1.38	▲ +41.3%
GAAP Gross Margin	49.8%	49.0%	▲ +0.2pp (QoQ)
GAAP Operating Margin	35.0%	34.0%	▲ +1.1pp (QoQ)

Source: Lam Research Corporation 8-K (April 22, 2026), Quiver Quantitative, StockTitan, GuruFocus

📈 Sequential Growth — Q3 vs Q2 FY2026 🚀

Revenue grew +9% sequentially from $5.345B in December 2025 to $5.84B in March 2026 — a new all-time company record. GAAP diluted EPS rose +15% QoQ from $1.26 to $1.45, while Non-GAAP EPS surged +16% QoQ from $1.27 to $1.47. GAAP operating margin expanded 110 basis points quarter-over-quarter, underscoring robust operating leverage as volumes scale.

🔍 Three-Year Revenue and EPS Progression

Quarter	Revenue	Non-GAAP EPS	YoY Revenue Growth
March 2024 (Q1 CY2024)	$3.70B	$0.779	—
March 2025 (Q1 CY2025)	$4.70B	$1.04	+27.0%
March 2026 (Q1 CY2026)	$5.84B ★ Record	$1.47	+23.8%

Over two years, LRCX revenue has surged +57.8% while Non-GAAP EPS has nearly doubled at +88.7% — demonstrating the significant operating leverage Lam Research extracts from its expanding installed base and CSBG (Customer Support Business Group) revenues.

💡 Business Segment Deep Dive

⚡ Systems vs. CSBG Revenue Mix

Lam Research's revenue comprises two major streams: Systems (new equipment sales) and CSBG (Customer Support Business Group — spares, upgrades, and services). In fiscal year 2025, cumulative CSBG revenue reached a record $7.2 billion annually, growing faster than installed-base unit growth. Total installed chambers crossed 100,000 units, creating a massive, recurring, and relatively cycle-resistant revenue engine that supports margin stability through industry downturns.

📌 Quarter Highlights at a Glance

Quarterly revenue of $5.84B — all-time record, up +9% vs. December 2025 quarter
GAAP operating margin 35.0% — expanded 110bps QoQ from 33.9%
Non-GAAP EPS $1.47 — beat consensus $1.36 by +8.1%
Installed chamber count surpassed 100,000 units globally
Advanced packaging revenue growth projected >40% in calendar 2026
Shareholder return commitment: ≥85% of free cash flow maintained
Fourth consecutive quarter of EPS outperformance vs. consensus

🔍 Check LRCX Live Stock Price

🎯 FY2026 Q4 Guidance — Another Record Quarter on the Horizon

The most market-moving element of Lam Research's April 22 release was its forward guidance for the June 2026 quarter. Management issued a revenue midpoint of $6.60 billion (±$400M) — implying a stunning +13% sequential revenue growth from the already-record March quarter. This guidance range of $6.20B–$7.00B dramatically exceeds pre-release analyst expectations.

📋 FY2026 Q4 (June Quarter) Official Guidance

Item	Midpoint	Guidance Range
Revenue	$6.60B	$6.20B – $7.00B
Gross Margin (GAAP / Non-GAAP)	49.0%	±1 percentage point
Operating Margin	~35%	±1 percentage point

Source: Lam Research 8-K Filing, StockTitan (April 22, 2026)

🔍 AI Semiconductor Demand — LRCX's Structural Growth Engine

⚡ WFE Market Outlook and Lam's Position

CEO Tim Archer stated on the earnings call that "AI transformation is driving industry spending structurally higher." Management projects the global Wafer Fabrication Equipment (WFE) market at approximately $135 billion in calendar 2026, with spending weighted to the second half of the year. Lam Research aims to expand its served available market (SAM) share of WFE into the mid-thirties percent range, up from historical levels.

🎁 Four Core Growth Catalysts for 2026

Advanced Packaging: Management projects >40% growth in 2026. AI accelerators and HBM stacking are driving unprecedented demand for Lam's etch and deposition tools in 2.5D/3D packaging architectures.
NAND High-Layer Upgrade Cycle: Lam's proprietary Cryo 3.0 technology enables customers to upgrade existing etch systems without full equipment replacement — a high-margin recurring revenue opportunity. CSBG NAND customer upgrade demand remains robust.
GAA (Gate-All-Around) Process Transition: The ramp of 2nm and below foundry nodes at TSMC and Samsung is driving a step-change increase in etch process steps per wafer. As the global etch market leader, Lam is positioned as an essential supplier for every advanced node transition.
DRAM / HBM Capacity Expansion: Capital expenditure expansion at SK Hynix, Samsung, and Micron for HBM3E and next-generation DRAM is directly translating into incremental deposition and etch tool orders for LRCX.

📌 China Exposure — Key Risk and Normalization Path

China revenue represented approximately 43% of Lam's revenue in fiscal 2025, but U.S. export control tightening is expected to reduce this to below 30% in fiscal 2026. Management estimates a ~$600M cumulative revenue headwind in 2026 from export restrictions, while remaining confident that global WFE spending growth will more than offset the impact. Korea (~15%) and Taiwan (~19%) provide meaningful geographic diversification.

💰 Balance Sheet and Capital Return Snapshot

Cash and equivalents: $6.2B (as of December 2025 quarter end)
Remaining share buyback authorization: $5.1B
March 2026 notes repayment: $750M planned
Free cash flow return policy: ≥85% to shareholders
Days Sales Outstanding (DSO): ~59 days
Inventory turns: ~2.7x
Capital expenditure guidance: 4%–5% of revenue

📋 Stock Reaction and Analyst Consensus

✅ After-Hours Price Action (April 22, 2026)

Following the earnings release, LRCX stock climbed +4.24% in after-hours trading, reaching $270.14 from a pre-release close of $258.37. The move added approximately $5.64 billion in market capitalization. Prior to this release, LRCX was trading within 5.53% of its 52-week high, outperforming peers AMAT, KLAC, TER, ASML, and ENTG, which all declined 1–3% on the session.

🔍 Wall Street Ratings and Price Targets

41 analysts rate LRCX as Buy, 5 as Hold, and only 1 as Sell, reflecting overwhelming bullish institutional consensus. The median 12-month price target from 19 analysts is $275.00. Full fiscal year 2026 EPS consensus is tracking toward $5.27, with annual revenue estimates at $22.56B — both likely to be revised upward following this beat-and-raise report. LRCX has now beaten EPS consensus in four consecutive quarters, with an average beat magnitude of approximately 7–10%.

📊 Lam Research vs. Semiconductor Equipment Peers

Company	Ticker	Specialty	Market Position
Lam Research	LRCX	Etch, Deposition	#1 Etch / #2 Deposition
Applied Materials	AMAT	Deposition, CMP	#1 Deposition
KLA Corporation	KLAC	Inspection, Metrology	#1 Inspection
ASML Holding	ASML	EUV Lithography	Monopoly in EUV

🔍 View LRCX News

🎯 Frequently Asked Questions (FAQ)

Q1. Did Lam Research beat Q1 2026 earnings estimates?

Yes. LRCX delivered a clear earnings beat: revenue came in at $5.84B vs. the consensus of $5.76–5.88B. Non-GAAP EPS of $1.47 beat the $1.36 estimate by 8.1%, and GAAP EPS of $1.45 exceeded the $1.35 estimate by 7.4%. This marks the fourth consecutive quarter of EPS outperformance.

Q2. What is Lam Research's revenue guidance for Q2 2026 (fiscal Q4)?

Lam guided fiscal Q4 2026 (quarter ending June 28, 2026) revenue at $6.60B ± $400M, implying a range of $6.20B to $7.00B. This is approximately +13% sequential growth from the March quarter record of $5.84B, and would represent another all-time revenue record if achieved.

Q3. What makes Lam Research a key AI semiconductor beneficiary?

Lam holds the #1 global market share in etch equipment and #2 in deposition. Every advanced AI chip — from TSMC's 2nm processes to HBM memory stacks — requires Lam's tools at multiple production stages. The combination of new equipment sales plus a 100,000+ chamber installed base generating recurring CSBG revenue creates a uniquely durable AI infrastructure exposure.

✅ Investor Checklist — LRCX Q1 2026

☑ Record quarterly revenue $5.84B — up +23.8% YoY, +9% QoQ
☑ Non-GAAP EPS $1.47 — beat consensus by +8.1%
☑ Four consecutive quarters of EPS beats
☑ June quarter guide: $6.60B — implies another record quarter
☑ AI / HBM / GAA process tailwinds remain structurally intact
☑ ≥85% FCF returned to shareholders — buyback + dividends
☑ China revenue normalizing to <30% — ongoing headwind monitored
☑ Valuation near 52-week high — premium pricing warrants attention
☑ 41 analyst Buy ratings, median price target $275

📌 Conclusion — LRCX Confirms Its Status as the AI Capex Backbone

Lam Research's Q1 2026 earnings report was a decisive beat-and-raise event across every key financial metric. Record revenue, expanding operating margins, a stellar EPS beat, and a blockbuster June quarter guide collectively reinforce LRCX's position as one of the most direct and durable beneficiaries of the global AI infrastructure investment cycle.

The structural demand drivers — GAA process transitions at leading foundries, HBM capacity expansions at memory chipmakers, and the emerging advanced packaging boom — are all multi-year tailwinds that directly map to Lam's etch and deposition leadership. With the installed base crossing 100,000 chambers and CSBG revenue growing faster than unit count, the recurring revenue flywheel adds a layer of earnings defensibility that traditional equipment-cycle analysis may underappreciate.

Key risks to monitor: China export control escalation (currently ~$600M 2026 impact), a potential semiconductor capex digestion pause, elevated valuation multiples, and clean-room capacity constraints that management flagged as a potential limiter on near-term WFE spending industry-wide.

⚠️ Investment Disclaimer

This article is provided for informational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Investing in stocks involves risk, including the possible loss of principal. Past earnings performance does not guarantee future results. All financial decisions should be made based on your own research and in consultation with a licensed financial advisor. All figures cited are sourced from official public filings and reputable financial data providers as of April 22–23, 2026.

Found this analysis useful? Share and bookmark it!

#LamResearch #LRCX #Q12026Earnings
#SemiconductorStocks #EarningsBeat #AIStocks
#WaferFabEquipment #HBM #AdvancedPackaging #USStocks